For example, CAFs derived from human epidermal growth factor receptor 2 (HER2+) breast cancers have increased expression of pathways associated with integrin signaling and the actin cytoskeleton, which may contribute to the fibroblast-driven collective invasion of cancer cells [34, 35]. The gene discussed is ERBB2; the disease is cancer.